Recent advances in bioactive materials: Future perspectives and opportunities in oral cancer biosensing

초록

Bioactive materials and biosensing technologies are emerging as pivotal tools in the early detection and management of oral cancer, a disease characterized by high morbidity and mortality rates. Recent advancements in nanotechnology have facilitated the development of innovative biosensors that utilize bioactive materials for non-invasive diagnostics, particularly through salivary analysis. These biosensors, including electrochemical, optical, and molecular types, target specific biomarkers such as DNA, RNA, and proteins associated with oral cancer. For instance, metal oxide nanoparticles and gold nanoparticles have shown promise in enhancing the sensitivity and specificity of these diagnostic tools. The integration of these nanomaterials allows for real-time monitoring of biomarker levels in saliva, providing a rapid and accurate means of detecting oral cancer at its nascent stages. Furthermore, the utilization of biosensors can circumvent the limitations of traditional biopsy methods, which are often invasive and time-consuming. By focusing on salivary diagnostics, researchers aim to develop point-of-care testing devices that can be used in various settings, thus improving accessibility to early screening for at-risk populations. This innovative approach not only enhances diagnostic accuracy but also holds potential for personalized treatment strategies by enabling continuous monitoring of disease progression and response to therapy. As research continues to evolve, the combination of bioactive materials with advanced biosensing technologies promises to revolutionize oral cancer diagnostics, ultimately leading to improved patient outcomes through earlier intervention and tailored therapeutic approaches.

키워드